A3AR Agonists May Help Prevent Chemotherapy-Induced Neuropathic Pain
A highly selective small molecule A3AR agonist blocked development of oxaliplatin-induced neuropathic pain without interfering with anticancer effects.
Source: CancerNetwork - Category: Cancer & Oncology Authors: John Schieszer Tags: Colorectal Cancer Gastrointestinal Cancer News Source Type: news
More News: Brain | Cancer | Cancer & Oncology | Chemotherapy | Colorectal Cancer | Eloxatin | Gastroenterology | Neurology | Pain